Test
No logo found
About Section Title (H2)
- This block can be used as an entry to deeper-level
- content for the user. Use an image
- that drives visual interest and
- explain the subject matter.
- Give the button an action-oriented title.
Related Content Title (H2)
Use this block to provide links to posts and pages in other parts of the site. When published, the featured image from the post or page will appear above the headline and excerpt in a traditional 3-across format.
Leadership Team
Leadership Team Brian Swift Title TBD Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Donec odio. Quisque volutpat mattis eros. Nullam malesuada erat ut turpis. Suspendisse urna nibh, viverra non, semper suscipit, posuere a, pede. Donec nec justo eget felis facilisis fermentum. Aliquam porttitor mauris sit amet orci. Aenean dignissim pellentesque felis. Morbi in sem quis dui placerat ornare. Pellentesque odio nisi, euismod in, pharetra a, ultricies in, diam. Sed arcu. Cras consequat. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Donec odio. Quisque volutpat mattis eros. Nullam malesuada erat ut turpis. Suspendisse urna nibh, viverra non, semper suscipit, posuere a, pede. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Donec odio. Quisque volutpat mattis eros. Nullam malesuada erat ut turpis. Suspendisse urna nibh, viverra non, semper suscipit, posuere a, pede. Darrin Grondel Vice President of Traffic Safety and Government Relations Dr. Grondel’s career began when he joined the Washington State Patrol as a trooper in 1992, where was promoted to sergeant, lieutenant and ultimately captain before retiring in 2017. During his time as captain, Governor Christine Gregoire appointed Dr. Grondel as director of the Washington Traffic Safety Commission (WTSC) in 2012. He was reappointed by Governor Inslee in 2013. Under his leadership, the WTSC led the passage of multiple traffic safety laws including impaired driving policies and distracted driving laws that resulted in improved enforcement and effectiveness. Dr. Grondel also directed Washington’s efforts to measure the effect of marijuana legalization on impaired driving. The data, programs, public education, research and policies he implemented to prevent drug-impaired driving and multi-substance impaired driving have provided a national model to address these emerging issues. As director of the WTSC, Dr. Grondel served as chair of the Washington Impaired Driving Advisory Council, the Traffic Records Committee, the Tribal Traffic Safety Advisory Board, and the Washington State Autonomous Vehicle Work Group. At the national level, Dr. Grondel served on the executive committee of the Governors Highway Safety Association (GHSA) Board of Directors, first as secretary and then as its chairman. He also serves on the Drug Evaluation and Classification Technical Advisory Panel, the Highway Safety Committee for the International Association of Chiefs of Police (IACP) and the National Sheriffs’ Association’s Traffic Safety Committee. Dr. Grondel has contributed to numerous national projects related to drug-impaired driving, autonomous vehicles, and national strategic efforts to reduce traffic fatalities to zero. Dr. Grondel has a doctorate of organizational leadership from Brandman University, a master of public administration from The Evergreen State College and a bachelor of political science from Brigham Young University. He lives outside of Seattle with his wife and children.
NASID Homepage
The National Alliance to Stop Impaired Driving (NASID) works to eliminate all forms of impaired driving, especially multiple substance impaired driving, through DUI system reform, DUI detection, data improvements and technology to effectively fight impaired driving. Our Purpose NASID provides national leadership to expand testing among impaired drivers, training for criminal justice practitioners, toxicology lab capacity improvements, and programs to increase likelihood of recovery and reductions in recidivism. Our work includes state and federal advocacy efforts, public awareness and education, and state implementation of effective programs. Upcoming Events State Laws and Statistics
Effective Solutions
Effective Solutions Use this text section to introduce the page’s content to the user. Donec sodales sagittis magna. Vestibulum facilisis, purus nec pulvinar iaculis, ligula mi congue nunc, vitae euismod ligula urna in dolor. Nunc nonummy metus. Aliquam lobortis. Quisque malesuada placerat nisl. Fusce vel dui. Phasellus dolor. Aenean vulputate eleifend tellus. Vivamus elementum semper nisi. Ut non enim eleifend felis pretium feugiat. Improved detection of impaired drivers Impaired driving is the only crime where an investigation ceases once minimal evidence is obtained. This results in many multiple substance-impaired drivers going undetected. Currently, many state policies and protocols prevent drug testing when an impaired driver has a blood alcohol concentration (BAC) level at or above the legal limit of .08 BAC the driver is only charged with DUI-alcohol. Drug use is usually only investigated when alcohol is ruled out as the cause of impairment or the impairment does not correspond with the driver’s BAC level. Data shows the need to test for both drugs and alcohol in order to better identify these dangerous drivers and ensure they are screened, assessed, sentenced, and treated in a way that positions them for rehabilitation and reduces future DUIs. The Orange County Crime Lab began testing all blood samples in DUI cases for the presence of drugs, irrespective of the BAC level, in August of 2017 with the goal of collecting better-impaired driving data. The most recent data (through December of 2018) reveals that impairing drugs were detected in 36% of samples where the BAC was .08 or greater which represents a 5% increase over the previous year (Harmon, 2019). Several oral fluid pilot studies also underscore the importance of testing drivers who have BACs above the illegal limit. In a study conducted in Miami-Dade County, 39% of drivers who were found to have a BAC above .08 also tested positive for the presence of drugs (Logan et al., 2014). In another pilot in Dane County, Wisconsin nearly 40% of the subjects with BACs exceeding .10 screened positive for one or more drug categories in both oral fluid and blood (Edwards et al., 2017). In a real-world setting, most of these individuals would only be identified as alcohol-impaired drivers and further investigation regarding drug use would be unlikely to occur. Why is Better Detection Critically Important? Failure to identify multiple substance and drug-impaired drivers can lead to negative outcomes: Lack of testing leads to under-reporting, limits overall understanding of the issue and prevents informed decision-making regarding policy and resource allocation. Failure to identify drug use at the time of arrest hinders the court’s ability to effectively dispose of cases and craft sentences tailored to offenders’ risk and needs. Unless drug use is identified at the outset of the case, offenders are unlikely to be subject to any drug monitoring and/or treatment, creating a missed opportunity to intervene and make informed offender supervision and treatment decisions that would reduce repeat DUIs. Solutions for Improving Detection A comprehensive approach should be implemented in order to identify drug and multiple substance impaired drivers, promote accountability and behavior change including: Increase specialized law enforcement training: Most law enforcement officers are trained to identify alcohol-impaired drivers, but many do not receive specialized training to identify the signs and symptoms of drug or multiple substance impairment. A complete investigation for drug-impaired driving requires an evaluation by a drug recognition expert (DRE). The nation needs more drug recognition experts, especially in rural areas and smaller police and sheriff’s departments. Advanced Roadside Impaired Driving Enforcement (ARIDE) training is the bridge between Standardized Field Sobriety Test (SFST) training. The greater the number of ARIDE-trained officers, the more likely that drug and polysubstance-impaired drivers will be identified and DREs will be called upon to perform drug evaluations. Expand drug testing for impaired drivers. Oral fluid tests are reliable and identify the presence of the most common categories of drugs. They are easy to administer in the field with quick results. They have a short detection window which captures recent as opposed to historical drug use. More jurisdictions are beginning to implement largescale oral fluid pilots or permanent programs as opposed to smaller county pilots. Michigan and Alabama both have statewide programs. These tests are not currently used for evidential purposes in the United States. A blood test is the gold standard for evidence in court. Expanded testing will strengthen DUI investigations and provide vital information to make appropriate sentencing, supervision, and treatment decisions. If drug use is not identified, the majority of these individuals are unlikely to be subject to drug testing or treatment interventions while under supervision which means that behavior change is unlikely and the potential for recidivism remains high. Learn more about oral fluid testing here (Link to OF position statement) Increase law enforcement ability to rapidly obtain chemical samples: Drug-impaired driving cases require a blood draw for evidential purposes and the delay in obtaining the blood sample is a substantial challenge. Impairment from drug use can last for hours, but the body metabolizes drugs quickly and chemical evidence dissipates rapidly. Law enforcement phlebotomy: One way to speed the process of blood collection is to train law enforcement officers as lab technicians so that they are fully trained to draw blood. This program was first established in Arizona more than two decades ago and is in place in 10 states. Law enforcement phlebotomy saves time and money and alleviates the challenge of performing blood draws in hospitals. Electronic warrants expedite warrant submission and approval, decrease human errors and speed the process for blood testing which will better match nanogram levels to what they were at the time of driving – in other words, the chemical evidence is preserved and not lost to metabolization. Examples of robust e-warrant systems can be found in Arizona, Minnesota, and Utah although each jurisdiction is encouraged to develop a system that is individualized such that it meets specific needs and garners support from key stakeholders. More information about these systems can be found in Responsibility.org’s Implementation Guide.
Example Blog 01
Example blog 01 excerpt Suspendisse quisque rutrum.
Example Blog 02
Example blog 02 excerpt Suspendisse quisque rutrum.
Example Blog 03
Example blog 03 excerpt Suspendisse quisque rutrum.
Event 2
May 12, 2021 @ 8:00 am – 5:00 pm
Details
- Date:
- May 12, 2021
- Time:
-
8:00 am – 5:00 pm
Event 1
May 12, 2021 @ 8:00 am – 5:00 pm
Details
- Date:
- May 12, 2021
- Time:
-
8:00 am – 5:00 pm
This is my text content block. This is my text content block.This is my text content block.This is my text content block.This is my text content block.
This is the title of the page. (H1)
This is descriptive text meant to help the user understand what the page is about. (Paragraph)